Henan Province announced the first batch of enterprises receiving "Science and Technology Vice Presidents", and Biocaro Pharmaceutical is proudly listed.

　　Recently, the Henan Provincial Committee of the Organization Department and the Provincial Department of Science and Technology jointly announced the list of enterprises receiving the first batch of "Science and Technology Vice Presidents" in Henan Province in 2024. A total of 626 enterprises were successfully selected, including Biocaro Pharmaceutical Co., Ltd.

　　It is understood that the 2024 Henan Province "Science and Technology Vice President" selection and dispatch work focuses on the "7+28+N" industrial clusters that our province is focusing on cultivating, focusing on supporting related enterprises in industrial clusters such as new materials, new energy vehicles, modern medicine, and modern food, and giving priority to the selection and dispatch to various innovative enterprises with provincial-level and above scientific and technological innovation platforms.

　　Biocaro Pharmaceutical, established in 2000, is a high-tech enterprise integrating the research, development, production, sales, and service of health food, functional food, disinfection products, and cosmetics. Over the years, the company has continuously increased its R&D investment and currently owns 15 national, provincial, and municipal-level technology platforms. It has initially built an innovation system with deep integration of production, education, research, and application, and has established cooperation with well-known universities such as Zhengzhou University and Nanjing University of Chinese Medicine, creating a series of core technologies and products with independent intellectual property rights. These achievements have not only enhanced the company's market competitiveness but also injected new vitality into local industrial upgrading and economic development.

　　As an enterprise with a significant influence in the greater health field, Biocaro Pharmaceutical has successfully attracted Xu Shuyu, a high-level scientific and technological talent from Henan University of Animal Husbandry and Economics, to serve as its "Science and Technology Vice President". Xu Shuyu is a doctor of Traditional Chinese Medicine Processing from Beijing University of Chinese Medicine. She has presided over or participated in a total of 6 national, provincial, and school-level projects, published 7 research papers as the first author or corresponding author, published 2 teaching and research papers, and has been granted 1 invention patent.

　　Biocaro Pharmaceutical's selection this time is not only an affirmation of its long-term adherence to an innovation-driven development strategy but also recognition of its achievements in promoting the deep integration of production, education, research, and application. The company will take this opportunity to further improve its full industrial chain, from Chinese herbal medicine planting, Chinese medicine slices, extraction, internal and external preparations to third-party testing, continue to increase its efforts in scientific and technological innovation, continuously improve product quality and service levels, and explore a path of health preservation rooted in China and serving the world.